Methods for Preventing Reactions Secondary to Cremophor El
- 1 November 1997
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 31 (11) , 1402-1404
- https://doi.org/10.1177/106002809703101120
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mechanism of Anaphylactoid Reactions: Improper Preparation of High-Dose Intravenous Cyclosporine Leads to Bolus Infusion of Cremophor El and CyclosporineAnnals of Pharmacotherapy, 1997
- Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.Journal of Clinical Oncology, 1996
- The Evolving Role of Paclitaxel in Breast Cancer and the Ambulatory Care SettingJournal of Pharmacy Practice, 1995
- Paclitaxel-induced severe hyper-sensitivity reaction occurring as a late toxicityAnnals of Oncology, 1995
- Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.Journal of Clinical Oncology, 1995
- Polysorbate 80 hypersensitivityThe Lancet, 1995
- Hypersensitivity Reactions to EtoposideAmerican Journal of Clinical Oncology, 1994
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990